Analysis of a vaccine model with cross-immunity: When can two competing infectious strains coexist?

Mathematical Biosciences

Volumn 234, Issue 1, 2011, Pages 33-46

  Dorigatti, Ilaria ^a   Pugliese, Andrea ^a  

^a UNIVERSITY OF TRENTO   (Italy)

Author keywords

Coexistence equilibrium; Cross immunity; Forward backward bifurcation; HIV; Vaccination rate; Vaccine model

Indexed keywords

COEXISTENCE EQUILIBRIUM; CROSS-IMMUNITY; FORWARD/BACKWARD BIFURCATION; HIV; VACCINATION RATE;

BLOWERS; VACCINES;

STRAIN;

HUMAN IMMUNODEFICIENCY VIRUS VACCINE;

BIFURCATION; HUMAN IMMUNODEFICIENCY VIRUS; INFECTIOUS DISEASE; MODELING; PATHOGEN; VACCINATION; VACCINE;

ARTICLE; BIOLOGICAL MODEL; CONTROLLED STUDY; CROSS REACTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYSTERESIS; INTRASPECIFIC COMPETITION; MATHEMATICAL ANALYSIS; NONHUMAN; SIMULATION; SPECIES COEXISTENCE; STRAIN DIFFERENCE; VACCINATION; VIRUS STRAIN; VIRUS TRANSMISSION;

CROSS REACTIONS; HIV INFECTIONS; HUMANS; MICROBIAL INTERACTIONS; MODELS, BIOLOGICAL; POPULATION DYNAMICS; VACCINES;

EID: 80054103146     PISSN: 00255564     EISSN: 18793134     Source Type: Journal    
DOI: 10.1016/j.mbs.2011.08.004     Document Type: Article

References (24)

1. Porco T.C., Blower S. Designing HIV vaccination policies: subtypes and cross-immunity. Interfaces 1998, 23:167.
2. Bremermann H.J., Thieme H.R. A competitive exclusion principle for pathogen virulence. J. Math. Biol. 1989, 27:179.
3. McLean A.R. Vaccination, evolution and changes in the efficacy of vaccine - a theoretical framework. Proc. R. Soc. Lond. Ser. B. Biol. Sci. 1995, 261:389.
4. Martcheva M., Bolker B.M., Holt R.D. Vaccine-induced pathogen strain replacement: what are the mechanisms?. J. Roy. Soc. 2008, 18(5):3.
5. Lipsitch M. Bacterial vaccines and serotype replacement: lessons from Haemophilus influenzae and prospects for Streptococcus pneumoniae. Emerg. Infect. Dis. 1999, 3(5):336.
6. Iannelli M., Martcheva M., Li X.Z. Strain replacement in an epidemic model with super-infection and perfect vaccination. Math. Biosci. 2005, 195(1):23.
7. Martcheva M. On the mechanism of strain replacement in epidemic models with vaccination. Current Developments in Mathematical Biology. Proceedings of the Conference on Mathematical Biology and Dynamical Systems 2006, 149. World Scientific, Hackensack, NJ. K. Mahadavi, R. Culshaw, J. Boucher (Eds.).
8. Porco T.C., Blower S. HIV vaccines: the effect of the mode of action on the coexistence of HIV subtypes. Math. Popul. Stud. 2000, 8(2):205.
9. Smith P.G., Rodrigues L.C., Fine P.E. Assessment of the protective efficacy of vaccines against common disease using case-control and cohort studies. Int. J. Epidemiol. 1984, 13:87.
10. Halloran M.E., Haber M., Longini I.M. Interpretation and estimation of vaccine efficacy under heterogeneity. Am. J. Epidemiol. 1992, 136:328.
11. Blower S.M., McLean A.R. Prophylactic vaccine, risk behaviour change, and the probability of eradicating HIV in San Francisco. Science 1994, 5177(265):1451.
12. Anderson R.M., May R.M. Infectious Diseases of Humans: Dynamics and Control 1991, Oxford University, Oxford.
13. Pugliese A. Population models for diseases with no recovery. J. Math. Biol. 1990, 28:65.
14. Murray J.D. Mathematical Biology I: An Introduction 2002, Springer-Verlag.
15. Britton N.F. Essential Mathematical Biology 2003, Springer.
16. Press W., Teukolsky S., Vetterling W., Flannery B. Numerical Recipes in C. The Art of Scientific Computing 1992, Cambridge University.
17. Andreasen V., Pugliese A. Pathogen coexistence induced by density dependent host mortality. J. Theor. Biol. 1995, 177:159.
18. Massad E., Coutinho F.A.B., Burattini M.N., Lopez L.F., Struchiner C.J. The impact of imperfect vaccines on the evolution of HIV virulence. Med. Hypotheses 2006, 66(5):907.
19. Thieme H.R., Castillo-Chavez C. How may infection-age-dependent infectivity affect the dynamics of HIV/AIDS?. SIAM J. Appl. Math. 1993, 53:1447.
20. Hughes J.P., Garnett G.P., Koutsky L. The theoretical population-level impact of a prophylactic Human Papilloma Virus vaccine. Epidemiology 2002, 13(6):631.
21. Levin S.A., Pimentel D. Selection for intermediate rates of increase in parasite-host systems. Am. Nat. 1981, 117:308.
22. Mosquera J., Adler F.R. Evolution of virulence: a unified framework for coinfection and superinfection. J. Theor. Biol. 1998, 195:293.
23. Troyer R.M., Collins K.R., Abraha A., Fraundorf E., Moore D.M., Krizan R.W., Toossi Z., Colebunders R.L., Jensen M.A., Mullins J.I., Vanham G., Arts E.J. Changes in human immunodeficiency virus type 1 fitness and genetic diversity during disease progression. J. Virol. 2005, 79:9006.
24. Ball C., Gilchrist M., Coombs D. Modeling within-host evolution of HIV: mutation, competition and strain replacement. Bull. Math. Biol. 2007, 69:2361.